Aktuellt
SENASTE
Despite a softer period for Vitrolife’s typically reliable Consumables and APAC, the company delivers a distinct positive surprise during Q2. The overall growth was 4%, with a positive outcome. The critical question is whether Vitrolife is now firmly on track to reinstalling a growth rate closer to its long-term target of >10%. We look forward to the call and expect a robust >5% positive share price reaction.
LÄS MER
